Suppr超能文献

婴幼儿、儿童及青少年初始万古霉素给药剂量的评估。

An evaluation of initial vancomycin dosing in infants, children, and adolescents.

作者信息

Broome Laura, So Tsz-Yin

机构信息

Department of Pharmacy, Moses H. Cone Memorial Hospital, Greensboro, NC 27401, USA.

出版信息

Int J Pediatr. 2011;2011:470364. doi: 10.1155/2011/470364. Epub 2011 Oct 23.

Abstract

Background. The pharmacokinetics of many medications change as we age, thus most would assume dosing strategies would adjust for these changes. The objective of this study is to evaluate the initial vancomycin dosing in three pediatric age groups based on measured serum trough concentrations. Methodology. This retrospective database review included patients aged from 1 month to 18 years old admitted to the Moses H. Cone Memorial Hospital. Patients had to have received vancomycin dosed at 15 mg/kg every 8 hours with an appropriately measured trough concentration. The primary outcome was to determine the percentage of patients in 3 pediatric age groups achieving therapeutic trough concentrations with the initial vancomycin dosing regimen. Results. Twenty-five patients were included in the study. None of the patients had therapeutic trough concentrations after receiving vancomycin 15 mg/kg every 8 hours. Only one patient had a supratherapeutic level, while all of the other patients had levels less than 10 mcg/mL. Conclusions. Vancomycin 15 mg/kg every 8 hours did not provide therapeutic serum trough concentrations for any pediatric age groups. Higher doses and/or more frequent dosing regimens need to be evaluated for each age group to determine the most appropriate strategies for producing therapeutic trough concentrations.

摘要

背景。许多药物的药代动力学随年龄增长而变化,因此大多数人会认为给药策略会针对这些变化进行调整。本研究的目的是根据测得的血清谷浓度评估三个儿科年龄组的万古霉素初始给药剂量。方法。这项回顾性数据库审查纳入了入住摩西·H·科恩纪念医院的1个月至18岁的患者。患者必须接受每8小时15mg/kg剂量的万古霉素治疗,并进行适当的谷浓度测量。主要结果是确定三个儿科年龄组中使用初始万古霉素给药方案达到治疗性谷浓度的患者百分比。结果。25名患者纳入研究。接受每8小时15mg/kg万古霉素治疗后,没有患者达到治疗性谷浓度。只有1名患者的血药浓度高于治疗水平,而其他所有患者的血药浓度均低于10mcg/mL。结论。每8小时15mg/kg的万古霉素剂量未能为任何儿科年龄组提供治疗性血清谷浓度。需要对每个年龄组评估更高剂量和/或更频繁的给药方案,以确定产生治疗性谷浓度的最合适策略。

相似文献

1
An evaluation of initial vancomycin dosing in infants, children, and adolescents.
Int J Pediatr. 2011;2011:470364. doi: 10.1155/2011/470364. Epub 2011 Oct 23.
2
Use of Body Surface Area for Dosing of Vancomycin.
J Pediatr Pharmacol Ther. 2019 Jul-Aug;24(4):296-303. doi: 10.5863/1551-6776-24.4.296.
4
Evaluation of a New Vancomycin Dosing Protocol in Morbidly Obese Patients.
Hosp Pharm. 2015 Oct;50(9):789-97. doi: 10.1310/hpj5009-789. Epub 2015 Oct 14.
5
An evaluation of vancomycin dosing for complicated infections in pediatric patients.
Hosp Pediatr. 2015 May;5(5):276-81. doi: 10.1542/hpeds.2014-0081.
6
Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.
J Pediatr Pharmacol Ther. 2009 Apr;14(2):86-93. doi: 10.5863/1551-6776-14.2.86.
7
Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review.
Pharm Pract (Granada). 2017 Apr-Jun;15(2):887. doi: 10.18549/PharmPract.2017.02.887. Epub 2017 Jun 30.
9
The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.
Pharmacotherapy. 2013 Dec;33(12):1264-72. doi: 10.1002/phar.1331. Epub 2013 Jul 17.
10
Vancomycin dosing in healthy-weight, overweight, and obese pediatric patients.
J Pediatr Pharmacol Ther. 2014 Jul;19(3):182-8. doi: 10.5863/1551-6776-19.3.182.

引用本文的文献

1
An evaluation of the empirical vancomycin dosing guide in pediatric cardiology.
BMC Pediatr. 2024 Sep 11;24(1):575. doi: 10.1186/s12887-024-05048-8.
3
Implementation of a Pharmacist-Driven Vancomycin and Aminoglycoside Dosing Service in a Pediatric Hospital.
J Pediatr Pharmacol Ther. 2022;27(4):340-346. doi: 10.5863/1551-6776-27.4.340. Epub 2022 May 9.
5
AUC- vs. Trough-Guided Monitoring of Vancomycin in Infants.
Indian J Pediatr. 2020 May;87(5):359-364. doi: 10.1007/s12098-019-03162-5. Epub 2020 Jan 27.
6
Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
Eur J Drug Metab Pharmacokinet. 2019 Dec;44(6):807-816. doi: 10.1007/s13318-019-00568-6.
7
Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital.
Paediatr Drugs. 2019 Aug;21(4):303-312. doi: 10.1007/s40272-019-00343-9.
8
Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.
J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):92-99. doi: 10.5863/1551-6776-23.2.92.
9
Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.
Eur J Clin Pharmacol. 2017 Nov;73(11):1341-1353. doi: 10.1007/s00228-017-2306-3. Epub 2017 Aug 4.
10
Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review.
Pharm Pract (Granada). 2017 Apr-Jun;15(2):887. doi: 10.18549/PharmPract.2017.02.887. Epub 2017 Jun 30.

本文引用的文献

1
Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.
J Pediatr Pharmacol Ther. 2009 Apr;14(2):86-93. doi: 10.5863/1551-6776-14.2.86.
2
Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.
J Antimicrob Chemother. 2011 Oct;66(10):2393-7. doi: 10.1093/jac/dkr285. Epub 2011 Jul 15.
3
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Ann Pharmacother. 2011 May;45(5):582-9. doi: 10.1345/aph.1P588. Epub 2011 Apr 26.
4
Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review.
Clin Ther. 2010 Jan;32(1):66-88. doi: 10.1016/j.clinthera.2010.01.019.
5
Use of linezolid in pediatrics: a critical review.
Int J Infect Dis. 2010 Aug;14(8):e638-48. doi: 10.1016/j.ijid.2009.10.002. Epub 2010 Jan 27.
9
Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
J Antimicrob Chemother. 1990 Apr;25(4):679-87. doi: 10.1093/jac/25.4.679.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验